Blood Flow Measurement Using Quantitative Magnetic Resonance Angiography and Duplex Sonography
Blood Flow Measurement in Cervical and Cerebral Arteries Using Quantitative Magnetic Resonance Angiography and Cervical and Transcranial Duplex Sonography
1 other identifier
observational
21
1 country
1
Brief Summary
The aim of the study is to assess the correlation of blood flow measurement in cervical and intracranial arteries between quantitative magnetic resonance angiography (qMRA) and duplex sonography (DS) and inter-/intra-investigators reliability of both methods in common clinical practice. A total of 21 subjects indicated to qMRA or DS for suspicion of cervical or intracranial vascular pathology will be included. All patients will undergo qMRA and DS of the cervical and intracranial arteries with measurement of blood flow in bilateral common carotid artery (CCA), internal carotid artery in proximal part distally to carotid bulb (ICA) and in distal carotid siphon (ICA-siphon), external carotid artery (ECA), vertebral artery in V2 (V2-VA) and V4 (V4-VA) segments, middle cerebral artery (MCA), anterior cerebral artery in pre-communicant (ACA1) and post-communicant (ACA2) part, posterior cerebral artery in pre-communicant (PCA1) and post-communicant (PCA2) part and basilar artery (BA) the cerebral artery. Correlations between measurements will be evaluated using Spearman's correlation coefficient or kappa coefficient and inter-class correlation coefficient (ICC).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedStudy Start
First participant enrolled
August 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2018
CompletedAugust 8, 2018
August 1, 2018
25 days
July 7, 2018
August 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood flow measurement
Correlation of blood flow measurement between qMRA and DS
6 weeks
Secondary Outcomes (3)
Intra-investigator reliability of quantitative magnetic resonance angiography
6 weeks
Inter-investigator reliability of duplex sonography
6 weeks
Intra-investigator reliability of duplex sonography
6 weeks
Study Arms (1)
Suspicion of vascular pathology
Subjects indicated to quantitative MR angiography and duplex sonography for suspicion of cervical or intracranial vascular pathology
Interventions
Quantitative MR angiography: A standard axial 3-dimensional time-of-flight (TOF) MRA of intracranial and cervical arteries will be obtained. Then, the acquired images will be transmitted to the workstation to reconstruct 3D surface-rendered vessel images. After determining optimal perpendicular scan plane and setting the baseline coordinates , retrospectively gated, fast 2-dimensional phase-contrast sequence will be performed. Velocity encoding will be automatically adjusted by NOVA software.
Duplex sonography of cervical arteries will be performed using 5 - 12 MHz linear duplex probe and transcranial color-coded duplex sonography will be performed using 2 - 5 MHz transcranial duplex probe. Peak systolic velocity, end diastolic celocity, mean blood flow velocity and arterial diameter will be measured with automatic calculation of blood flow velocity in each arterial segment.
Eligibility Criteria
Subjects indicated to qMRA or DS for suspicion of cervical or intracranial vascular pathology will be included
You may qualify if:
- male or female
- age 25 - 70 years
- suspicion of cervical or intracranial vascular pathology
- signed informed consent.
You may not qualify if:
- contraindication to magnetic resonance
- uncontrolled involuntary movements
- other condition preventing long-term quiet lying.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Palacky Universitylead
- České Budějovice Hospitalcollaborator
Study Sites (1)
Nemocnice Ceske Budejovice
České Budějovice, Czechia
Study Officials
- PRINCIPAL INVESTIGATOR
David Skoloudik, Prof. Dr.
Palacký University Olomouc, Center for Science and Research
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Manager
Study Record Dates
First Submitted
July 7, 2018
First Posted
July 19, 2018
Study Start
August 6, 2018
Primary Completion
August 31, 2018
Study Completion
August 31, 2018
Last Updated
August 8, 2018
Record last verified: 2018-08